‘TaIL’ – An International update on Targeted and Immunotherapy in Lung cancer – 2018
Dr. Ramprasad, Medgenome
Topic: Basics Science of EGFR pathway and its implications
Time: 7.30 to 8 pm
Dr. T.P. Sahoo
Topic: First line therapy in EGFR positive NSCLC
Time: 8.30 to 9 pm
Dr. Natasha Leighl
Topic: Beyond First line therapy in EGFR positive NSCLC
Time: 9 to 9.30 pm
Dr. Pavithran, Dr. Ravi Diwakar, Dr. Murali Subramanian, Dr. Sajeevan, Dr. Tejendar Singh, Dr. Anilkumar
Topic: Panel Discussion, Dr. Ullas Batra
Time: 9.30 to 10 pm
Enquire
Now 